KROS EV/EBITDA
0.22
-0.13-37.14%
Wed, 22 Jan 2025 00:35:50 GMT
Summary:
As of January 22, 2025, KROS EV/EBITDA is 0.22, with a fall of -0.13 (-37.14%) during the most recent trading day. Over the past year, it has increased by +10.41 (+102.16%). KROS EV/EBITDA is now -53.19% below its all-time high of 0.47.KROS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -37.1% |
| 1 m1 month | +121.6% |
| 3 m3 months | +102.2% |
| 6 m6 months | +102.9% |
| ytdytd | +131.4% |
| 1 y1 year | +102.2% |
| 5 y5 years | - |
KROS EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 0.47 | -53.2% | -1.02 | +121.6% |
| 3 m | 3-month | 0.47 | -53.2% | -12.22 | +101.8% |
| 6 m | 6-month | 0.47 | -53.2% | -12.22 | +101.8% |
| 1 y | 1-year | 0.47 | -53.2% | -14.58 | +101.5% |
| 3 y | 3-year | 0.47 | -53.2% | -21.38 | +101.0% |
| 5 y | 5-year | 0.47 | -53.2% | -47.80 | +100.5% |
| alltime | all time | 0.47 | -53.2% | -47.80 | +100.5% |
Keros Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.22(-131.4%) |
| 2024 | -0.70(-88.8%) |
| 2023 | -6.23(-38.7%) |
| Date | Value |
|---|---|
| 2022 | -10.16(-51.2%) |
| 2021 | -20.83(-31.3%) |
| 2020 | -30.30 |
FAQ
- What is Keros Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Keros Therapeutics?
- What is KROS EV/EBITDA year-to-date change?
- What is Keros Therapeutics EV/EBITDA year-on-year change?
What is Keros Therapeutics EV/EBITDA?
The current EV/EBITDA of KROS is 0.22
What is the all time high EV/EBITDA for Keros Therapeutics?
Keros Therapeutics all-time high EV/EBITDA is 0.47
What is KROS EV/EBITDA year-to-date change?
Keros Therapeutics EV/EBITDA has changed by +0.92 (+131.43%) since the beginning of the year
What is Keros Therapeutics EV/EBITDA year-on-year change?
Over the past year, KROS EV/EBITDA has changed by +10.41 (+102.16%)